ALSO READThermo Fisher acquires Johnson Matthey's Alfa Aesar for Pound 256 mn ICMR's biomedical research centre in Hyderabad receives Cabinet nod Regulators tighten scrutiny of India clinical research firms India clinical research market: Rebounding from post-2011 slump Zydus to start phase-II clinical trials for Saroglitazar in US
Thermo Fisher Scientific, which provides technology and equipment to science-based industries such as pharma, biotech, chemical, etc, has opened its Good manufacturing practices (GMP) facility in Singapore to address the growing demand for clinical services in Asia. Having established its first clinical services facility in Singapore in 2001, the move to this newly built facility will meet the growing demand for clinical supply services in the region. The new site will provide both regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies - from GMP storage, local labelling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies to returns management.
Located in Toh Guan Road, Jurong East - the hub for Singapore’s biomedical and pharmaceutical companies - the new facility is nearly 70,000 square feet (6,500sqm), more than 60 percent larger than the previous site and double the cold chain capacity.
“Asia Pacific continues to be our fastest-growing market and a central contributor to our growth. For nearly 15 years, Singapore has been the central hub for our Asia-Pacific operations, due to its strategic location. With the opening of our larger and well-equipped facility, we aim to continue to build on our Singapore facility further and on the expertise of our local team, to strengthen our regional and global presence in the clinical supplies industry,” said Leon Wyszkowski, Thermo Fisher’s vice president of clinical services for North America and facility network.
The clinical services facility is also well-equipped with improved technologies and operational tools to serve a growing need for clinical supplies and trials in the region. This includes a larger storage system for its clinical supplies, a new climatic control energy consumption system that reduces the facility’s carbon footprint, and an overall building monitoring system that provides staff with timely updates on the facility’s conditions.